Zacks Investment Research
18 Nov 2025, 17:46 UTC · 43w ago
Verdict
Headline takes no side. We score AMWL −0.80 across four claims — strongly bearish.
−0.80strongly bearish
More negative than 87% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Hims & Hers Health (HIMS) projects full-year 2025 revenues between $2.335 billion and $2.355 billion, representing growth of 58%-59% over 2024.
More positive than 91% of claims this week
The company experienced a contraction in both margins and disappointing bottom-line results in the third quarter of 2025.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 81% of claims this week
Hims & Hers faces increasing regulatory complexity related to its expansion into peptide manufacturing, sterile compounding, and laboratory testing.
More negative than 73% of claims this week
HIMS stock has underperformed the S&P 500 and its broader industry sector, losing 15.6% over the past three months.
More negative than 62% of claims this week
Which stocks this story touches
More negative than 87% of ticker scores this week
The company's shares have experienced a significant loss of 44.2% over the past three months.
More negative than 77% of ticker scores this week
The company's shares have lost 8% over the past three months.
More negative than 74% of ticker scores this week
While top-line growth is robust, the company reported disappointing bottom-line results, margin contraction, and faces increasing regulatory complexity.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1d ago
More positive than 35% of relationship scores this week
[mutual] The article identifies Teladoc Health as a peer of Hims & Hers.
More positive than 7% of relationship scores this week
[mutual] Both are identified as peers within the same industry/sector as Hims & Hers.
+247.2%
Price is moving against the score
$13.75 vs $3.96 close before publication (Nov 17) · not market-adjusted
AMWL chart →
